[go: up one dir, main page]

ATE3774T1 - Beclomethason-ester-solvate, verfahren zu ihrer herstellung und herstellung einer formulierung. - Google Patents

Beclomethason-ester-solvate, verfahren zu ihrer herstellung und herstellung einer formulierung.

Info

Publication number
ATE3774T1
ATE3774T1 AT80102385T AT80102385T ATE3774T1 AT E3774 T1 ATE3774 T1 AT E3774T1 AT 80102385 T AT80102385 T AT 80102385T AT 80102385 T AT80102385 T AT 80102385T AT E3774 T1 ATE3774 T1 AT E3774T1
Authority
AT
Austria
Prior art keywords
preparation
formulation
beclomethasone
beclomethasone ester
solvate
Prior art date
Application number
AT80102385T
Other languages
English (en)
Inventor
Lawrence Edward Finckenor
Original Assignee
Schering Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corporation filed Critical Schering Corporation
Application granted granted Critical
Publication of ATE3774T1 publication Critical patent/ATE3774T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT80102385T 1980-05-02 1980-05-02 Beclomethason-ester-solvate, verfahren zu ihrer herstellung und herstellung einer formulierung. ATE3774T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP80102385A EP0039369B1 (de) 1980-05-02 1980-05-02 Beclomethason-ester-solvate, Verfahren zu ihrer Herstellung und Herstellung einer Formulierung
AU58107/80A AU533551B2 (en) 1980-05-02 1980-05-06 Beclomethasone eser solvates

Publications (1)

Publication Number Publication Date
ATE3774T1 true ATE3774T1 (de) 1983-06-15

Family

ID=25631966

Family Applications (1)

Application Number Title Priority Date Filing Date
AT80102385T ATE3774T1 (de) 1980-05-02 1980-05-02 Beclomethason-ester-solvate, verfahren zu ihrer herstellung und herstellung einer formulierung.

Country Status (3)

Country Link
EP (1) EP0039369B1 (de)
AT (1) ATE3774T1 (de)
AU (1) AU533551B2 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR890000664B1 (ko) * 1981-10-19 1989-03-22 바리 안소니 뉴우샘 미분된 베클로메타손 디프로피오네이트 일수화물의 제조방법
DK336485A (da) * 1984-07-25 1986-01-26 Hovione Int Ltd Fremgangsmaade til fremstilling af et diisopropylaetersolvat af beclomethason-17,21-dipropionat
GB8432063D0 (en) * 1984-12-19 1985-01-30 Riker Laboratories Inc Physically modified steroids
ATE204743T1 (de) 1991-12-18 2001-09-15 Minnesota Mining & Mfg Aerosolzusammensetzungen für arzneimittelsuspensionen
US7101534B1 (en) 1991-12-18 2006-09-05 3M Innovative Properties Company Suspension aerosol formulations
US7105152B1 (en) 1991-12-18 2006-09-12 3M Innovative Properties Company Suspension aerosol formulations
MX9304585A (es) 1992-07-31 1994-03-31 Glaxo Group Ltd Formulacion farmaceutica en aerosol, lata adecuada para liberar la formulacion e inhalador de dosis dosificada que comprende la lata.
DE4433374A1 (de) * 1994-09-20 1996-03-21 Hoechst Ag 17-Desoxi-corticosteroid-21-/O/-Carbonsäure- ester, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
US7090830B2 (en) 2001-05-24 2006-08-15 Alexza Pharmaceuticals, Inc. Drug condensation aerosols and kits
US7766013B2 (en) 2001-06-05 2010-08-03 Alexza Pharmaceuticals, Inc. Aerosol generating method and device
US20070122353A1 (en) 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
US7585493B2 (en) 2001-05-24 2009-09-08 Alexza Pharmaceuticals, Inc. Thin-film drug delivery article and method of use
US7458374B2 (en) 2002-05-13 2008-12-02 Alexza Pharmaceuticals, Inc. Method and apparatus for vaporizing a compound
US7645442B2 (en) 2001-05-24 2010-01-12 Alexza Pharmaceuticals, Inc. Rapid-heating drug delivery article and method of use
WO2003026631A1 (en) * 2001-05-24 2003-04-03 Alexza Molecular Delivery Corporation Delivery of drug esters through an inhalation route
US6737042B2 (en) 2001-05-24 2004-05-18 Alexza Molecular Delivery Corporation Delivery of drug esters through an inhalation route
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
US7582284B2 (en) 2002-04-17 2009-09-01 Nektar Therapeutics Particulate materials
US7913688B2 (en) 2002-11-27 2011-03-29 Alexza Pharmaceuticals, Inc. Inhalation device for producing a drug aerosol
JP2007516149A (ja) 2003-05-21 2007-06-21 アレックザ ファーマシューティカルズ, インコーポレイテッド 基板温度の均一性を制御する方法、および、内蔵式加熱ユニットおよびそれを使用する薬剤供給ユニット
US7540286B2 (en) 2004-06-03 2009-06-02 Alexza Pharmaceuticals, Inc. Multiple dose condensation aerosol devices and methods of forming condensation aerosols
EP2246086A3 (de) 2004-08-12 2012-11-21 Alexza Pharmaceuticals, Inc. Aerosolverabreichungsvorrichtung mit Schlag gezündete Heizeinheit
EP2120875B1 (de) 2007-02-11 2018-07-11 Map Pharmaceuticals Inc. Verfahren zur therapeutischen verabreichung von dhe zur schnellen linderung von migräne bei gleichzeitiger minimierung von nebenwirkungsprofilen
ES2594867T3 (es) 2007-03-09 2016-12-23 Alexza Pharmaceuticals, Inc. Unidad de calentamiento para usar en un dispositivo de administración de fármaco
GB0914240D0 (en) * 2009-08-14 2009-09-30 Breath Ltd Steroid solvates
KR102852740B1 (ko) 2018-02-02 2025-08-29 알렉스자 파마스티칼즈, 인크. 전기적 응축 에어로졸 디바이스

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1429184A (en) * 1972-04-20 1976-03-24 Allen & Hanburys Ltd Physically anti-inflammatory steroids for use in aerosols
MX3864E (es) * 1975-05-27 1981-08-26 Syntex Corp Un proceso para prepara el compuesto cristalino 6-fluiro-11b 21-dihiroxi-16 17-isopropilidendioxipregna-1 4-dien-3 20-diona

Also Published As

Publication number Publication date
EP0039369B1 (de) 1983-06-15
AU533551B2 (en) 1983-12-01
EP0039369A1 (de) 1981-11-11
AU5810780A (en) 1981-11-19

Similar Documents

Publication Publication Date Title
ATE3774T1 (de) Beclomethason-ester-solvate, verfahren zu ihrer herstellung und herstellung einer formulierung.
ATE8790T1 (de) Aromatische heterocyclische steroidester, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten.
AT360654B (de) Verfahren zur herstellung von pharmazeutischen zusammensetzungen
ATE1241T1 (de) Verfahren zur herstellung von 4,5-perfluor-1,3-dioxolanen.
SE8100134L (sv) Terpenoider, forfaranden for framstellning av desamma och farmaceutiska kompositioner innehallande desamma
ATA907180A (de) Verfahren zur herstellung einer topischen benzoylperoxidzusammensetzung
ATA6280A (de) Verfahren zur herstellung einer gewingeschneidschraube und nach dem verfahren hergestellte gewindeschneidschraube
DD131019A5 (de) Verfahren zur herstellung eines 2-desoxystreptaminaminoglycosides
AT367295B (de) Verfahren zur herstellung von pharmazeutischen zusammensetzungen
ATE489T1 (de) Sila-substituierte 1,4-dihydropyridinderivate, verfahren zu ihrer herstellung, arzneimittel und verfahren zu deren herstellung.
AR241108A2 (es) Insecticidas piretroides, acidos ciclopropancarboxilicos y esteres intermediarios y sus precedimientos de preparacion
ZA792043B (en) Esters of substituted 8-hydroxy-1-phenyl-2,3,4,5-tetrahydro-1h-3-benzazepines,process for the preparation thereof and pharmaceutical compositions containing them
PT69999A (de) 1,2,3-triazolcarbonsaureamide verfahren zur herstellung dieser verbindungen sowie diese enthaltende biozide mittel
ATA814276A (de) Verfahren zur herstellung des neuen 2,6- dimethyl-3-metoxycarbonyl-4-(2'-nitrophenyl)- 1,4-dihydropyridin-5-carbonsaeureisobutylesters
DD137352A5 (de) Verfahren zur herstellung von n hoch 2-arylsulfonyl-l-argininamiden und ihrer pharmaz5utisch vertraeglichen salze
DD136832A5 (de) Verfahren zur herstellung von 1,2-dichloraethan
DD129979A5 (de) Verfahren zur herstellung von polyjodderivaten von benzol
ATA63776A (de) Verfahren zur herstellung von 1,2-benzisothiazolen
AT379167B (de) Verfahren zur herstellung einer aerosolzusammensetzung
DD135497A5 (de) Verfahren zur herstellung von 17 beta hydroxy-4-androsten-3-onen
DD134769A1 (de) Verfahren zur herstellung von 3-oxo-oestra-4,9,11-trienen
PT71265A (de) Verfahren zur herstellung von 5-mercapto-1,2,3-triazolen
AT350558B (de) Verfahren zur herstellung von 2,4-dioxo- oxazolidinen
ATA128180A (de) Verfahren zur herstellung einer verarbeitungsfertigen lagerbestaendigen feuerfesten weitgehend geruchsfreien masse
AT347919B (de) Verfahren zur herstellung von 2,2-dimethyl-3- (2',2'-dihalogenvinyl)-cyclopropan-1- carbonsaeureestern

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee